Form 8-K - Current report:
SEC Accession No. 0001493152-25-003316
Filing Date
2025-01-23
Accepted
2025-01-23 08:15:20
Documents
16
Period of Report
2025-01-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52330
2 ex3-1.htm EX-3.1 15741
3 ex99-1.htm EX-99.1 14162
  Complete submission text file 0001493152-25-003316.txt   321954

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cdt-20250122.xsd EX-101.SCH 3883
5 XBRL DEFINITION FILE cdt-20250122_def.xml EX-101.DEF 30185
6 XBRL LABEL FILE cdt-20250122_lab.xml EX-101.LAB 37007
7 XBRL PRESENTATION FILE cdt-20250122_pre.xml EX-101.PRE 27208
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6271
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 25547682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)